[The behavior of serum immunoglobulins in patients treated with methyl-hydrazine].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007136:Immunoglobulins / Q000032:analysis*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012507:Sarcoidosis / Q000188:drug therapy / Q000276:immunology; D014581:Urticaria / Q000188:drug therapy / Q000276:immunology
D006834:Hydrazines; D007136:Immunoglobulins
Il comportamento delle immunoglobuline sieriche in pazienti trattati con metil-idrazina.